Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward D Verrier

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Circulation|October 31, 2007
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophyRafal Pawlinski, Michael Tencati, Craig R Hampton, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2015
Gamification in thoracic surgical education: Using competition to fuel performanceNahush A Mokadam, Richard Lee, Ara A Vaporciyan, et al.
JAMA|May 20, 2004
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trialEdward D Verrier, Stanton K Shernan, Kenneth M Taylor, et al.
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Circulation|October 31, 2007
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophyRafal Pawlinski, Michael Tencati, Craig R Hampton, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2015
Gamification in thoracic surgical education: Using competition to fuel performanceNahush A Mokadam, Richard Lee, Ara A Vaporciyan, et al.
JAMA|May 20, 2004
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trialEdward D Verrier, Stanton K Shernan, Kenneth M Taylor, et al.
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Pageof 9